Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,427,000 | 7,335,000 | 7,721,000 | 6,687,000 | 7,339,000 |
| Marketable Securities | N/A | N/A | N/A | 2,535,000 | N/A |
| Receivables | 8,857,000 | 9,371,000 | 10,324,000 | 9,902,000 | 10,502,000 |
| Inventories | 6,512,000 | 6,880,000 | 7,860,000 | 7,267,000 | 7,516,000 |
| Other current assets | 10,992,000 | 11,387,000 | 3,783,000 | 4,151,000 | 3,413,000 |
| TOTAL | $36,788,000 | $34,973,000 | $29,688,000 | $30,542,000 | $28,770,000 |
| Non-Current Assets | |||||
| PPE Net | 15,905,000 | 16,434,000 | 18,278,000 | 18,197,000 | 17,575,000 |
| Investments And Advances | 0 | 0 | 0 | 10,748,000 | 0 |
| Intangibles | 53,944,000 | 54,969,000 | 58,501,000 | 58,867,000 | 59,712,000 |
| Other Non-Current Assets | 18,740,000 | 19,392,000 | 18,865,000 | 7,900,000 | 18,537,000 |
| TOTAL | $88,589,000 | $90,795,000 | $95,644,000 | $95,712,000 | $95,824,000 |
| Total Assets | $125,377,000 | $125,768,000 | $125,332,000 | $126,254,000 | $124,594,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,937,000 | 7,556,000 | 6,009,000 | 6,776,000 | 7,656,000 |
| Accounts payable and accrued liabilities | 4,520,000 | 4,991,000 | 5,485,000 | 6,148,000 | 5,079,000 |
| Other current liabilities | 12,587,000 | 12,786,000 | 13,266,000 | 10,935,000 | 13,077,000 |
| TOTAL | $26,616,000 | $27,556,000 | $24,760,000 | $26,368,000 | $25,812,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,670,000 | 12,874,000 | 15,202,000 | 11,242,000 | 11,119,000 |
| Other Non-Current Liabilities | 14,650,000 | 14,791,000 | 15,007,000 | 7,239,000 | 15,452,000 |
| TOTAL | $27,337,000 | $27,695,000 | $30,236,000 | $25,414,000 | $26,603,000 |
| Total Liabilities | $53,953,000 | $55,251,000 | $54,996,000 | $51,782,000 | $52,415,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 1,001,000 | N/A |
| Retained earnings | N/A | N/A | N/A | 73,431,000 | N/A |
| Other shareholders' equity | 71,424,000 | 70,517,000 | 70,336,000 | 129,000 | 72,179,000 |
| TOTAL | $71,424,000 | $70,517,000 | $70,336,000 | $74,472,000 | $72,179,000 |
| Total Liabilities And Equity | $125,377,000 | $125,768,000 | $125,332,000 | $126,254,000 | $124,594,000 |